Published in Eur J Haematol on May 01, 2003
Histone deacetylase inhibitor romidepsin has differential activity in core binding factor acute myeloid leukemia. Clin Cancer Res (2008) 0.94
Direct assessment of P-glycoprotein efflux to determine tumor response to chemotherapy. Biochem Pharmacol (2010) 0.85
Wilms' tumor 1 mutation accumulated during therapy in acute myeloid leukemia: Biological and clinical implications. Leukemia (2006) 1.74
Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery. Br J Surg (1992) 1.59
Multiplex reverse transcription-polymerase chain reaction for simultaneous screening of 29 translocations and chromosomal aberrations in acute leukemia. Blood (1998) 1.42
The importance of KRAS mutations and EGF61A>G polymorphism to the effect of cetuximab and irinotecan in metastatic colorectal cancer. Ann Oncol (2009) 1.40
[Granulocyte-macrophage colony-stimulating factor. Treatment of patients with highly malignant lymphomas and acute lymphoblastic leukemias after autologous bone marrow transplantation]. Ugeskr Laeger (1992) 1.38
Somatic MED12 mutations in uterine leiomyosarcoma and colorectal cancer. Br J Cancer (2012) 1.24
Mutational analysis of the tumour suppressor gene MMAC1/PTEN in malignant myeloid disorders. Eur J Haematol (2000) 1.22
Purification and characterization of fetal hematopoietic cells that express the common acute lymphoblastic leukemia antigen (CALLA). J Exp Med (1983) 1.16
Murine helix-loop-helix transcriptional activator proteins binding to the E-box motif of the Akv murine leukemia virus enhancer identified by cDNA cloning. Mol Cell Biol (1992) 1.16
Extensive intra- and interindividual heterogeneity of p15INK4B methylation in acute myeloid leukemia. Cancer Res (1999) 1.07
CPP1, a DNA-binding protein involved in the expression of a soybean leghemoglobin c3 gene. Proc Natl Acad Sci U S A (2000) 1.04
Interferon enhances the antibody-dependent cellular cytotoxicity (ADCC) of human polymorphonuclear leukocytes. J Immunol (1981) 1.04
DAP-kinase CpG island methylation in acute myeloid leukemia: methodology versus biology? Blood (2000) 0.99
Analysis of leucocyte differentiation antigens in blood and bone marrow from patients with Waldenström's macroglobulinaemia. Br J Haematol (1987) 0.99
Female haemophilia A in a family with seeming extreme bidirectional lyonization tendency: abnormal premature X-chromosome inactivation? Clin Genet (1989) 0.98
Natural killer cell activity correlates with the amount of beta 2-microglobulin on human peripheral blood lymphocytes. Cell Immunol (1982) 0.96
[Blood transfusion increases the risk of surgical infection]. Ugeskr Laeger (1993) 0.96
Purification of common acute lymphoblastic leukemia antigen positive cells from normal human bone marrow. Blood (1984) 0.96
Cleaved intracellular plasminogen activator inhibitor 2 in human myeloleukaemia cells is a marker of apoptosis. Br J Cancer (1994) 0.95
Fate of tumor cells injected into left ventricle of heart in BALB/c mice: role of natural killer cells. J Natl Cancer Inst (1988) 0.95
KRAS-mutated plasma DNA as predictor of outcome from irinotecan monotherapy in metastatic colorectal cancer. Br J Cancer (2013) 0.94
Quantitative assessment of the JAK2 V617F allele burden: equivalent levels in peripheral blood and bone marrow. Leukemia (2007) 0.93
A new class of plant homeobox genes is expressed in specific regions of determinate symbiotic root nodules. Plant Mol Biol (1999) 0.92
Determination of recognition-sequences for DNA-binding proteins by a polymerase chain reaction assisted binding site selection method (BSS) using nitrocellulose immobilized DNA binding protein. Nucleic Acids Res (1992) 0.91
Natural killer (NK)-cell activity and antibody-dependent cellular cytotoxicity (ADCC) in primary preleukemic syndrome. Leuk Res (1984) 0.91
Orderly expression of B cell antigens during the in vitro differentiation of nonmalignant human pre-B cells. J Immunol (1985) 0.89
Basic helix-loop-helix proteins in murine type C retrovirus transcriptional regulation. J Virol (1994) 0.89
An improved technique for obtaining E rosettes with human lymphocytes and its use for B cell purification. J Immunol Methods (1976) 0.89
Presence of clone-specific markers at birth in children with acute lymphoblastic leukaemia. Br J Cancer (2002) 0.89
Kinetics of BCR-ABL fusion transcript levels in chronic myeloid leukemia patients treated with STI571 measured by quantitative real-time polymerase chain reaction. Eur J Haematol (2002) 0.88
Rapid and sensitive minimal residual disease detection in acute leukemia by quantitative real-time RT-PCR exemplified by t(12;21) TEL-AML1 fusion transcript. Genes Chromosomes Cancer (1999) 0.88
[Extramedullary manifestations among adult patients with acute lymphoblastic leukemia (ALL)]. Ugeskr Laeger (1991) 0.88
Bcl-xL anti-apoptotic network is dispensable for development and maintenance of CML but is required for disease progression where it represents a new therapeutic target. Leukemia (2013) 0.87
Endogenous and adoptively transferred A-NK and T-LAK cells continuously accumulate within murine metastases up to 48 h after inoculation. In Vivo (1999) 0.87
Two small lymphocyte subpopulations in human peripheral blood. I. Purification and surface marker profiles. Int Arch Allergy Appl Immunol (1978) 0.86
13-cis retinoic acid treatment of myelodysplastic syndromes. Leuk Res (1987) 0.86
R-CHOEP-14 improves overall survival in young high-risk patients with diffuse large B-cell lymphoma compared with R-CHOP-14. A population-based investigation from the Danish Lymphoma Group. Ann Oncol (2011) 0.85
Breast tumour as a first manifestation of extramedullary relapse in acute lymphoblastic leukaemia. Scand J Haematol (1984) 0.84
Sustained major molecular response on interferon alpha-2b in two patients with polycythemia vera. Ann Hematol (2008) 0.84
Identification and cloning of a prethymic precursor T lymphocyte from a population of common acute lymphoblastic leukemia antigen (CALLA)-positive fetal bone marrow cells. J Exp Med (1987) 0.84
Optimization of a flow cytometric method for the simultaneous measurement of cell surface antigen, DNA content, and in vitro BrdUrd incorporation into normal and malignant hematopoietic cells. Cytometry (1998) 0.84
Analysis of leukocyte differentiation antigens in blood and bone marrow from preleukemia (refractory anemia) patients using monoclonal antibodies. Blood (1986) 0.83
Expression of TEL-AML1 fusion transcripts and response to induction therapy in standard risk acute lymphoblastic leukemia. Leuk Lymphoma (2001) 0.83
A two-color flow cytometry assay for detection of hairy cells using monoclonal antibodies. Blood (1987) 0.83
Optimization of a method for simultaneous analysis of cell surface phenotype and cell cycle in human bone marrow and peripheral blood leukocytes by flow cytometry: the value of both internal and external standards. Anal Cell Pathol (1993) 0.82
Characterization of t(12;21) breakpoint junctions in acute lymphoblastic leukemia. Leukemia (2001) 0.82
Comparison between 125IUdR and 51Cr as cell labels in investigations of tumor cell migration. Int J Rad Appl Instrum B (1990) 0.82
A quantitative evaluation of erythropoiesis in myelodysplastic syndromes using multiparameter flow cytometry. Leuk Res (1993) 0.81
A novel type of DNA-binding protein interacts with a conserved sequence in an early nodulin ENOD12 promoter. Plant Mol Biol (1996) 0.81
Enumeration of organ-associated natural killer cells in mice: application of a new stereological method. APMIS (1992) 0.80
Detection of mutations in GC-rich DNA by bisulphite denaturing gradient gel electrophoresis. Nucleic Acids Res (1998) 0.79
Malignant monoblasts can function as effector cells in natural killer cell and antibody-dependent cellular cytotoxicity assays. Blood (1981) 0.79
Identification and cloning of differentially expressed genes by DDRT-PCR. Methods Mol Biol (1997) 0.79
Effect of recombinant alpha interferon on NK and ADCC function in lung cancer patients: results from a phase II trial. J Interferon Res (1984) 0.79
Natural killer function following allogeneic bone marrow transplantation. Very early reemergence but strong dependence of cytomegalovirus infection. Transplantation (1988) 0.79
Trisomy 10 survival: a literature review and presentation of seven new cases. Cancer Genet Cytogenet (1998) 0.79
The multimeric structure of plasma F VIII:RAg studied by electroelution and immunoperoxidase detection. Thromb Res (1986) 0.79
Relation of blast cell survival and proliferation to chemotherapy resistance in AML. Br J Haematol (1996) 0.78
Many unbalanced translocations show duplication of a translocation participant. Clinical and cytogenetic implications in myeloid hematologic malignancies. Am J Hematol (2000) 0.78
Familial Alzheimer's disease co-segregates with a Met146I1e substitution in presenilin-1. Clin Genet (1996) 0.78
The use of monoclonal antibodies in clinical haematology--the art of limitation. Scand J Haematol (1984) 0.78
Development of standardized approaches to reporting of minimal residual disease data using a reporting software package designed within the European LeukemiaNet. Leukemia (2011) 0.78
Selective effects of alpha interferon on human T-lymphocyte subsets during mixed lymphocyte cultures. Scand J Immunol (1983) 0.78
Interferon-induced augmentation of cytotoxic killer cell generation in mixed lymphocyte cultures: analysis of the effector cell product. Scand J Immunol (1981) 0.78
MDR1 gene expression and drug resistance of AML cells. Br J Haematol (1998) 0.77
Induced and down-regulated proteins in the human cultured hairy cell leukemia line JOK-1 and the Burkitt's lymphoma cell line Daudi during incubation with interferon-alpha: a kinetic study. J Interferon Res (1992) 0.77
Biology of multiple drug resistance in acute leukemia. Int J Hematol (2000) 0.77
Immunomodulation of NK and ADCC by Corynebacterium parvum in acute myeloid leukaemia patients. Leuk Res (1985) 0.77
Flow cytometric identification of myeloid disorders by asynchronous expression of the CD14 and CD66 antigens. Eur J Haematol (1998) 0.77
Human lymphocyte and mouse erythrocyte rosettes. Optimization of the assay. Scand J Haematol (1981) 0.77
Infiltration patterns of short- and long-term cultured A-NK and T-LAK cells following adoptive immunotherapy. Scand J Immunol (1998) 0.77
Pregnancy zone protein: a re-evaluation of serum levels in healthy women and in women suffering from breast cancer or trophoblastic disease. Scand J Clin Lab Invest (1990) 0.77
Pretreatment leukaemia cell drug resistance is correlated to clinical outcome in acute myeloid leukaemia. Eur J Haematol (2001) 0.76
Long-term culture of hematopoietic stem cells - validating the stromal component of the CAFC assay. Cytotherapy (2001) 0.76
Surface expression of the alpha 2-macroglobulin receptor on human malignant blood cells. Leuk Res (1992) 0.76
Effect of psychological intervention in the form of relaxation and guided imagery on cellular immune function in normal healthy subjects. An overview. Psychother Psychosom (1990) 0.76
Erythropoietin receptor defect: a cause of primary polycythaemia. Br J Haematol (2004) 0.76
Adjuvant immune stimulation with Corynebacterium parvum during maintenance chemotherapy of acute myeloid leukemia. A prospective randomized study. Cancer Immunol Immunother (1983) 0.76
IFN-induced modulation of histocompatibility antigens on human cells. Background, mechanisms and perspectives. Cancer Metastasis Rev (1988) 0.76
Differential expression levels of the heat shock protein 27 isoforms in pediatric normal, nonleukemic and common acute lymphoblastic leukemia B-cell precursors. Blood (1995) 0.76
Stereological analysis of the ultrastructure in isolated human T and non-T lymphoid cells. I. Description of method and data on normal blood lymphocytes. Virchows Arch B Cell Pathol Incl Mol Pathol (1982) 0.76
Roquinimex (Linomide) vs placebo in AML after autologous bone marrow transplantation. Bone Marrow Transplant (2000) 0.76
Expression of differentiation and activation antigens on peripheral blood mononuclear cells in chronic lymphocytic leukaemia (CLL) and in hairy-cell leukaemia (HCL) Eur J Haematol (1990) 0.75
[Scientific reporting--any future development?]. Ugeskr Laeger (1999) 0.75
The relationship between human T-lymphocyte subsets defined by monoclonal antibodies and by avidity differences to sheep erythrocytes. Acta Pathol Microbiol Immunol Scand C (1982) 0.75
Ultrastructure of normal human blood T lymphocyte subsets isolated by cell sorting using monoclonal antibodies. A stereological analysis. Virchows Arch B Cell Pathol Incl Mol Pathol (1982) 0.75
Human peripheral blood lymphocytes. Isolation, subset characterization and in vitro properties. A review of the literature of the 1970s. Acta Pathol Microbiol Scand Suppl (1981) 0.75